1. Genotoxicity analysis of a flame retardant, aluminum diethylphosphinate.
- Author
-
Leoncio TOL, Fernandes AS, Felzenszwalb I, Araujo-Lima CF, Oliveira DP, Dorta DJ, Sampaio CF, and Ferraz ERA
- Subjects
- Humans, Micronucleus Tests, Hep G2 Cells, Mutagenicity Tests, Phosphinic Acids toxicity, Microsomes drug effects, Microsomes metabolism, Salmonella drug effects, Salmonella genetics, Cell Membrane drug effects, Flame Retardants toxicity
- Abstract
Flame retardants, crucial for fire prevention, are used worldwide, but they are considered to be 'emerging contaminants' and may pose risks to human and environmental health. Aluminum diethyl phosphinate (ALPI) is a halogen-free flame retardant. To evaluate the toxicity of this compound, the following assays were performed: Salmonella/microsome mutagenicity assay; toxicity assays with two endpoints (mitochondrial dehydrogenase activity, plasma membrane integrity); micronucleus assay with human hepatoma cell line HepG2. ALPI was not mutagenic in Salmonella strains TA97, TA98, TA100, TA102, or TA104. ALPI was not cytotoxic at any concentration tested. The HepG2 micronucleus assay showed genotoxicity of ALPI at 200 µg/mL and no cytotoxicity (cytokinesis-block proliferation index, CBPI). Our data are relevant to the regulation of flame retardants., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Israel Felzenszwalb reports financial support was provided by State University of Rio de Janeiro Biomedical Centre. Israel Felzenszwalb reports financial support was provided by Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State. Israel Felzenszwalb reports financial support was provided by National Council for Scientific and Technological Development. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF